Study of Noscapine for Patients With Low Grade Non Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia Refractory to Chemotherapy

Inclusion Criteria: * Patients with low grade NHL (follicular lymphoma, small cell lymphocytic lymphoma, marginal cell lymphoma, monocytoid B-cell lymphoma, MALT lymphoma, plasmacytoid lymphocytic lymphoma) or chronic lymphocytic leukemia who have demonstrated chemotherapy resistance (have not achieved CR,CRu, PR)or who have relapsed at any time following a response (CR, CRu, PR) after at least one therapy regimen, including chemotherapy, Rituximab, or high dose chemotherapy with stem cell rescue. * Karnofsky performance status 60 % or greater. * Creatinine less or equal to 2.0 mg/dl, bilirubin less or equal to 2.0 mg/dl, SGPT/SGOT less or equal to 4 x upper normal range Exclusion Criteria: * Patients with unconfirmed complete response(CRu)after last treatment and who currently remain in CRu. * Pregnant or lactating women. * Disease-specific treatment less than 1 month prior to starting this study. * CNS disease. * HIV-positive patients. * Other cancer, except basal cell or squamous cell cancer of the skin or carcinoma in-situ of cervix.